One Equity Partners Completes Acquisition of PeroxyChem

One Equity Partners, the global private investment arm of J.P. Morgan Chase & Co., announced today the completion of the acquisition of PeroxyChem, formerly FMC Global Peroxygens, a business division of FMC Corporation specializing in peroxygen chemistries. The acquisition includes all sales, manufacturing, and supply chain and R&D capabilities of FMC Global Peroxygens and was valued at approximately $200 million.

This acquisition enables PeroxyChem to extend its market position as a global leader in the manufacturing of hydrogen peroxide, persulfates, peracetic acid and environmental remediation technologies while continuing to provide customized solutions, technical expertise and ongoing support to existing and new customers. PeroxyChem expects no changes to daily operations as a result of the sale.

Read More